Article Details

Merck bolsters oncology pipeline with $2.75B deal for Calif. biopharma firm

Retrieved on: 2020-11-04 23:45:00

Tags for this article:

Click the tags to see associated articles and topics

Merck bolsters oncology pipeline with $2.75B deal for Calif. biopharma firm. View article details on hiswai:

Excerpt

<div>... a privately held clinical-stage <b>biopharmaceutical</b> company focused on cancer therapies, the Kenilworth-based drugmaker announced Thursday.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up